Keyphrases
Tuberous Sclerosis Complex
100%
New Therapeutics
100%
Epilepsy
100%
Mammalian Target of Rapamycin Pathway
75%
Seizure
50%
Targeted Therapy
25%
Multi-organ
25%
Brain-damaged Patients
25%
Unmet Needs
25%
Susceptible Individuals
25%
Epileptogenesis
25%
Prominent Features
25%
Epilepsy Treatment
25%
Downstream Effectors
25%
Antiepileptogenic
25%
Seizure Generation
25%
Recurrent Seizures
25%
Pharmacology, Toxicology and Pharmaceutical Science
Disease Model
100%
Tuberous Sclerosis
100%
Mammalian Target of Rapamycin
75%
Epileptogenesis
25%
Diseases
25%
Neuroscience
Tuberous Sclerosis
100%
Mammalian Target of Rapamycin
75%
Epileptogenesis
25%
Treatment of Epilepsy
25%